Controlled Trial of Oxprenolol and Practolol in Hypertension

Leishman, A. W. D.; Thirkettle, J. L.; Allen, B. R.; Dixon, R. A.
November 1970
British Medical Journal;11/7/1970, Vol. 4 Issue 5731, p342
Academic Journal
No abstract available.


Related Articles

  • Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy. Gallery, E.D.M.; Saunders, D.M.; Hunyor, S.N.; Gyory, A.Z. // British Medical Journal;6/16/1979, Vol. 1 Issue 6178, p1591 

    Reports the comparison of methyldopa and oxprenolol drugs for treatment of hypertension in pregnancy. Differences in the outcome of the treatment between the two drugs; Effectiveness of oxprenolol in controlling hypertension during pregnancy; Advantages of oxprenolol over methyldopa.

  • Trial of combination of guanethidine and oxprenolol in hypertension. Pearson, R.M.; Bending, M.R.; Bulpitt, C.J.; George, C.F.; Hole, D.R.; Williams, F.M.; Breckenridge, A.M. // British Medical Journal;4/17/1976, Vol. 1 Issue 6015, p933 

    Focuses on the clinical trial of guanethidine and oxprenolol combination in hypertensive patients. Evidence of additive effect on blood pressure; Effect of the combination on heart rate; Absence of correlation between the plasma oxprenolol concentration and changes in blood pressure.

  • Propranolol, oxprenolol, and sclerosing peritonitis . Marigold, J.H.; Pounder, R.E.; Pemberton, J. // British Medical Journal (Clinical Research Edition);3/20/1982, Vol. 284 Issue 6319, p870 

    Examines the effect of propranolol, oxprenolol on sclerosing peritonitis. Association of practolol with oculomucocutaneous syndrome; Assessment on radiological appearances of patients taking propranolol and oxprenolol; Implication of oxprenolol on sclerosing peritonitis.

  • oxprenolol. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p578 

    An encyclopedia entry for "oxprenolol" is presented. It refers to a beta-blocker drug used in the treatment of hypertension, angina and cardiac arrhythmias. It may also be used to relieve symptoms of anxiety and control those of hyperthyroidism.

  • Atenolol, sustained-release oxprenolol, and long-acting propranolol in hypertension. Petrie, J.C.; Jeffers, T.A.; Robb, O.J.; Scott, A.K.; Webster, J. // British Medical Journal;6/28/1980, Vol. 280 Issue 6231, p1573 

    Evaluates the effect of atenolol, sustained-release oxprenolol and long-acting propranolol in hypertension. Formulation of sustained-release oxprenolol; Increase in post-exercise heart rate; Comparison of the efficacy of propranolol and oxprenolol.

  • Use of beta-blocking agents with group therapy in a smoking withdrawal clinic. Dow, Robert J.; Fee, Walter M. // Journal of the Royal Society of Medicine;Aug1984, Vol. 77 Issue 8, p648 

    A controlled trial was carried out into the relative efficacy of two beta-blocking agents (oxprenolol and metoprolol) as adjuncts to group therapy in a smoking withdrawal clinic. There was no evidence to indicate that these were of specific value in assisting smoking withdrawal.

  • Antinuclear antibodies in patients receiving non-practolol beta-blockers. Wilson, J.D.; Bullock, Jocelyn Y.; Sutherland, D.C.; Main, C.; O'Brien, K.P. // British Medical Journal;1/7/1978, Vol. 1 Issue 6104, p14 

    Antinuclear antibodies (ANA) were found in 54 (7.0%) out of 767 treated hypertensive patients compared with 59 (2.4%) out of 2470 healthy controls. Inclusion of a non-practolol beta-blocker in the treatment regimen did not significantly affect the incidence of ANA. ANA was found in significantly...

  • Renal function in patients with essential hypertension receiving nadolol. Waal-Manning, H.J.; Hobson, C.H. // British Medical Journal;8/9/1980, Vol. 281 Issue 6237, p423 

    Investigates the renal hypertension in patients with diagnosis of nadolol dose. Physiological effect of propranolol and oxprenolol on renal function; Effectiveness of antihypertensive dose of nadolol; Description of nadolol.

  • Presentation and analysis of the results of clinical trials in cardiovascular disease. Hampton, J.R. // British Medical Journal (Clinical Research Edition);4/25/1981, Vol. 282 Issue 6273, p1371 

    Evaluates the result of clinical trials in cardiovascular disease. Reduction of mortality after myocardial infarction; Comparison of oxprenolol and disopyramide with placebo treatment results; Infusion of anturane reinfarction.

  • CORRESPONDENCE. Wald, N.; Cuckle, Howard S.; Harwood, Catherine A.; Nysenbaum, A.; McFarlane, T.; Gadd, R.L.; Preston, Noel W.; Jackson, G.A.; Banks, A.W.; Hutchins, C.J.; Orme, M. L'Estrange; Serlin, M.J.; Breckenridge, A.; Sandler, Bernard; Lasagna, L.; Freedman, B.J.; Grace, A.J.; Ebbing, R.N. // British Medical Journal;8/4/1979, Vol. 2 Issue 6185, p331 

    Reports issues related to medicine. Introduction of routine antenatal screening for open neural-tube defects; Efficacy of oxprenolol in treating hypertension in pregnancy; Effectiveness of vaccines in preventing whooping-cough.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics